Revision Optics, a US-based developer of medical device treatments for eye disorders, raised $32m yesterday in a funding round led by healthcare group Johnson & Johnson.
The corporate, which invested through its Johnson & Johnson Development Corporation (JJDC) unit, was joined by Canaan Partners, Domain Associates, Interwest Partners and Proquest Investments.
Founded in 1996, Revision Optics has created an implant similar to a contact lens to treat presbyopia, an age-related condition that results in a worsening vision with symptoms such…
